ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	26/173	191/7206	3.44550831397e-13
ko04621	NOD-like receptor signaling pathway	23/173	157/7206	1.87082020755e-12
ko04380	Osteoclast differentiation	21/173	134/7206	4.86668856884e-12
ko04064	NF-kappa B signaling pathway	18/173	96/7206	7.81136342194e-12
ko05145	Toxoplasmosis	19/173	126/7206	1.07971387456e-10
ko04217	Necroptosis	22/173	178/7206	1.82403172967e-10
ko05168	Herpes simplex infection	22/173	182/7206	2.82522014074e-10
ko05164	Influenza A	21/173	167/7206	3.52987636798e-10
ko05321	Inflammatory bowel disease (IBD)	13/173	56/7206	4.31629671886e-10
ko05152	Tuberculosis	21/173	187/7206	2.90552698679e-09
ko04658	Th1 and Th2 cell differentiation	15/173	96/7206	6.66121209336e-09
ko04630	Jak-STAT signaling pathway	17/173	132/7206	1.30279571392e-08
ko05340	Primary immunodeficiency	9/173	30/7206	1.99611597311e-08
ko04659	Th17 cell differentiation	15/173	106/7206	2.67926551017e-08
ko04660	T cell receptor signaling pathway	16/173	124/7206	3.47253057121e-08
ko05162	Measles	15/173	120/7206	1.45915304757e-07
ko05140	Leishmaniasis	12/173	75/7206	1.75672919744e-07
ko04622	RIG-I-like receptor signaling pathway	11/173	62/7206	1.95311106867e-07
ko04612	Antigen processing and presentation	12/173	77/7206	2.37025789796e-07
ko04620	Toll-like receptor signaling pathway	13/173	100/7206	6.47854363496e-07
ko05160	Hepatitis C	16/173	153/7206	6.67077617592e-07
ko05161	Hepatitis B	17/173	173/7206	7.16056876253e-07
ko05167	Kaposi's sarcoma-associated herpesvirus infection	17/173	191/7206	2.86228825371e-06
ko04650	Natural killer cell mediated cytotoxicity	12/173	97/7206	3.02972146353e-06
ko04668	TNF signaling pathway	13/173	120/7206	5.25590182265e-06
ko04662	B cell receptor signaling pathway	11/173	88/7206	7.15999670793e-06
ko05330	Allograft rejection	6/173	24/7206	1.64977606988e-05
ko04672	Intestinal immune network for IgA production	7/173	37/7206	2.2817275358e-05
ko05310	Asthma	5/173	17/7206	3.68577115362e-05
ko04623	Cytosolic DNA-sensing pathway	7/173	41/7206	4.59511581378e-05
ko05320	Autoimmune thyroid disease	6/173	29/7206	5.26963099318e-05
ko04210	Apoptosis	14/173	180/7206	9.9612425784e-05
ko04640	Hematopoietic cell lineage	8/173	64/7206	0.000132031287275
ko04611	Platelet activation	13/173	163/7206	0.000137837501682
ko05150	Staphylococcus aureus infection	6/173	36/7206	0.000187968077496
ko05416	Viral myocarditis	7/173	55/7206	0.000312644542925
ko04062	Chemokine signaling pathway	14/173	201/7206	0.000318349520308
ko05169	Epstein-Barr virus infection	14/173	206/7206	0.000409235305288
ko05332	Graft-versus-host disease	4/173	18/7206	0.00075444589752
ko05323	Rheumatoid arthritis	8/173	89/7206	0.00126691841694
ko04145	Phagosome	11/173	162/7206	0.00172274284874
ko03050	Proteasome	6/173	54/7206	0.00174462433762
ko04664	Fc epsilon RI signaling pathway	7/173	77/7206	0.0023816365516
ko04610	Complement and coagulation cascades	7/173	79/7206	0.00275818715045
ko04670	Leukocyte transendothelial migration	10/173	151/7206	0.00332678608922
ko05131	Shigellosis	7/173	82/7206	0.00340677885382
ko04514	Cell adhesion molecules (CAMs)	9/173	130/7206	0.00393743886845
ko05144	Malaria	5/173	45/7206	0.00422856765841
ko05166	HTLV-I infection	15/173	292/7206	0.00501759250152
ko04940	Type I diabetes mellitus	4/173	32/7206	0.00682683114268
ko05418	Fluid shear stress and atherosclerosis	10/173	173/7206	0.00859463490126
ko04666	Fc gamma R-mediated phagocytosis	8/173	122/7206	0.0088686840404
ko05142	Chagas disease (American trypanosomiasis)	8/173	130/7206	0.0127388005842
ko05215	Prostate cancer	7/173	111/7206	0.017097092841
ko04917	Prolactin signaling pathway	6/173	87/7206	0.0178610345504
ko04657	IL-17 signaling pathway	6/173	87/7206	0.0178610345504
ko05133	Pertussis	6/173	87/7206	0.0178610345504
ko05146	Amoebiasis	6/173	99/7206	0.0314021339111
ko04933	AGE-RAGE signaling pathway in diabetic complications	7/173	135/7206	0.0434499383007
ko05212	Pancreatic cancer	5/173	83/7206	0.0487814024131